{"id":755884,"date":"2023-05-08T08:15:12","date_gmt":"2023-05-08T12:15:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/"},"modified":"2023-05-08T08:15:12","modified_gmt":"2023-05-08T12:15:12","slug":"benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/","title":{"rendered":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HAYWARD, Calif., May  08, 2023  (GLOBE NEWSWIRE) &#8212; Benitec Biopharma Inc. (NASDAQ: BNTC) (\u201cBenitec\u201d or \u201cCompany\u201d), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&#8220;ddRNAi&#8221;) platform, today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16<sup>th<\/sup>, 2023 at 2:00 pm ET.<\/p>\n<p align=\"justify\">A live webcast of the presentation will be accessible from the Investor section of Benitec\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jomsql41pdtB9WfrKXNFG7Y0_nyzIYGQ0t7Qhr0zdWLnVTrfSAyJCusUHGDD8hxYR525GhuoyZkr_pN5Un1K6A==\" rel=\"nofollow noopener\" target=\"_blank\">ir.benitec.com<\/a>. An archived version of the webcast will be available in the Events section of the Investors page of Benitec\u2019s website for 90 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Benitec Biopharma Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Benitec Biopharma Inc. (\u201cBenitec\u201d or the \u201cCompany\u201d) is a development-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). A comprehensive overview of the Company can be found on Benitec\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kieXwmZh8C7GT5dDFzqhXmh1iTdFrEluHk1ig3B309bIxpS3jvz9tRWk10a5nhxYXYvq1X2f7XlHvYLgXGEqOg==\" rel=\"nofollow noopener\" target=\"_blank\">www.benitec.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Investor Relations Contact:<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">William Windham<br \/>VP, Solebury Strategic Communications<br \/>Phone: 646-378-2946<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EtzPW7at1C8vcmPwld8dptwYf9u5nb8bW9uhpB3D8CX_DKS2sZqARBUELrJOLZs2-CcgEaDgsRXo1DPci5Ya69TDkjCwCVt0ZfriYPoDvZoWzA789ib7hEDSCIJWlszV\" rel=\"nofollow noopener\" target=\"_blank\">wwindham@soleburystrat.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTUxZjljNTgtOTI0OC00OGEwLTk2ZTMtNDk0ZDlkOTgxYmQzLTEyNjI2MjQ=\/tiny\/Benitec-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Benitec Biopharma Inc. (NASDAQ: BNTC) (\u201cBenitec\u201d or \u201cCompany\u201d), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&#8220;ddRNAi&#8221;) platform, today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm ET. A live webcast of the presentation will be accessible from the Investor section of Benitec\u2019s website at ir.benitec.com. An archived version of the webcast will be available in the Events section of the Investors page of Benitec\u2019s website for 90 days following the event. About Benitec Biopharma Inc. Benitec Biopharma Inc. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Benitec Biopharma to Present at the JMP Securities Life Sciences Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755884","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Benitec Biopharma Inc. (NASDAQ: BNTC) (\u201cBenitec\u201d or \u201cCompany\u201d), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&#8220;ddRNAi&#8221;) platform, today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm ET. A live webcast of the presentation will be accessible from the Investor section of Benitec\u2019s website at ir.benitec.com. An archived version of the webcast will be available in the Events section of the Investors page of Benitec\u2019s website for 90 days following the event. About Benitec Biopharma Inc. Benitec Biopharma Inc. &hellip; Continue reading &quot;Benitec Biopharma to Present at the JMP Securities Life Sciences Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T12:15:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference\",\"datePublished\":\"2023-05-08T12:15:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/\",\"name\":\"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\",\"datePublished\":\"2023-05-08T12:15:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk","og_description":"HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Benitec Biopharma Inc. (NASDAQ: BNTC) (\u201cBenitec\u201d or \u201cCompany\u201d), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&#8220;ddRNAi&#8221;) platform, today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm ET. A live webcast of the presentation will be accessible from the Investor section of Benitec\u2019s website at ir.benitec.com. An archived version of the webcast will be available in the Events section of the Investors page of Benitec\u2019s website for 90 days following the event. About Benitec Biopharma Inc. Benitec Biopharma Inc. &hellip; Continue reading \"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-08T12:15:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference","datePublished":"2023-05-08T12:15:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/","name":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=","datePublished":"2023-05-08T12:15:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzYzMSM1NTc5MjkzIzIyNTEwNzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/benitec-biopharma-to-present-at-the-jmp-securities-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Benitec Biopharma to Present at the JMP Securities Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755884"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755884\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}